STAAR Surgical Company (STAA) Stock Overview
Explore STAAR Surgical Company’s financial performance, market position, analyst ratings, and future outlook.
STAAR Surgical Company (STAA)
Key Financials
Key Financials
Market Cap
1.1B
P/E Ratio
314.34
EPS (TTM)
$0.57
ROE
0.01%
STAA Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of STAAR Surgical Company (NASDAQ: STAA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, STAAR Surgical Company's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of STAA on the NASDAQ shows an RSI of 39.47, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $18.39 for the NASDAQ listing.
Key metrics behind STAAR Surgical Company's NASDAQ-traded stock include a P/E ratio of 314.34 and a market capitalization of 1.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of STAA on the NASDAQ.